Table 1.
Patients and disease characteristics
| Characteristics | Study population N=9 |
||
| N | % | ||
| Age (years) | Median Range min-max |
54 34–87 |
– – |
| Gender | Male Female |
3 6 |
33 67 |
| ECOG PS | 0 1 |
6 3 |
67 33 |
| Primary tumour resection | No Yes |
1 8 |
11 89 |
| Metastatic sites (N) | 1 >1 |
5 4 |
56 44 |
| Synchronous mets | No Yes |
4 5 |
44 56 |
| Line of anti-EGFR tx (N) | 1–2 >2 |
3 6 |
33 67 |
| Regimen | Panitumumab Panitumumab plus irinotecan Cetuximab plus irinotecan |
5 2 2 |
56 22 22 |
Mets, metastases; tx, treatment.